🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The aim of the study is to investigate the safety, tolerability, efficacy a...
Status
Completed
Location
1199.120.001 Boehringer Ingelheim Investigational Site
Start Date
2012-05
Trial ID
NCT01594125
The aim of this study was to evaluate the efficacy of two different doses o...
Status
Completed
Location
Multiple Locations
Start Date
2005-11
Trial ID
NCT02182063
Treatments Being Tested
This phase I, open label dose escalation study will investigate the additio...
Status
Terminated
Location
1199.117.003 Boehringer Ingelheim Investigational Site
Start Date
2011-04
Trial ID
NCT01329549
RATIONALE: Low-dose cytarabine works in a minority of elderly patients with...
Status
Unknown
Location
Universitätsklinikum Münster, Medizinische Klinik und Poliklinik A
Start Date
2012-03
Trial ID
NCT01488344
Treatments Being Tested
Phase I study. To determine the MTD (Maximum Tolerated Dose) of nintedanib ...
Status
Completed
Location
HOP d'Angers
Start Date
2016-03-07
Trial ID
NCT02668393
Treatments Being Tested
The purposes of this study are to: 1. evaluate potential interactions betw...
Status
Recruiting
Location
Research Site
Start Date
2026-04-28
Trial ID
NCT07454291
Treatments Being Tested
The objectives of this trial are to estimate the following in Japanese pati...
Status
Terminated
Location
1199.28.003 Boehringer Ingelheim Investigational Site
Start Date
2009-10-16
Trial ID
NCT00979576
Acute exacerbations of idiopathic pulmonary fibrosis (AE-IPF) are sudden an...
Status
Recruiting
Location
Department of Respiratory Medicine, University Hospital of Patras
Start Date
2026-01-25
Trial ID
NCT07299695
Treatments Being Tested
The aim of this trial is to offer continuation of BIBF 1120 treatment for p...
Status
Completed
Location
INSARES
Start Date
2010-06-25
Trial ID
NCT01170065
To investigate safety of BIBF 1120 in Japanese patients with idiopathic pul...
Status
Completed
Location
1199.31.002 Boehringer Ingelheim Investigational Site
Start Date
2010-05
Trial ID
NCT01136174